Showing results (1051-1060 of 9,923) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|August 18, 2009
Successful SCT for Nijmegen breakage syndromeM H Albert, A R Gennery, J Greil, et al.
Bone Marrow Transplantation|October 27, 2009
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALLS Giebel, B Stella-Holowiecka, M Krawczyk-Kulis, et al.
Bone Marrow Transplantation|February 16, 2010
Monitoring the international use of unrelated donors for transplantation: the WMDA annual reportsL M Foeken, A Green, C K Hurley, et al.
Bone Marrow Transplantation|February 23, 2010
The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese populationG Q Wu, Y M Zhao, X Y Lai, et al.
Bone Marrow Transplantation|September 6, 2016
Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA studyA Sirvent, P Auquier, C Oudin, et al.
Bone Marrow Transplantation|September 13, 2016
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomesJ E Brammer, R M Saliba, J L Jorgensen, et al.
Bone Marrow Transplantation|September 20, 2016
Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximabV Bhatt, L Shune, E Lauer, et al.
Bone Marrow Transplantation|June 27, 2017
Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHDM Y Shapira, A Klimov, S Vipul, et al.
Bone Marrow Transplantation|June 27, 2017
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and EurocordS Nguyen, A Achour, L Souchet, et al.
Bone Marrow Transplantation|June 6, 2017
Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemiaR Zhang, W Shi, H-F Wang, et al.
Pageof 993